SymBio Pharmaceuticals Limited 4582.T Stock
SymBio Pharmaceuticals Limited Price Chart
SymBio Pharmaceuticals Limited 4582.T Financial and Trading Overview
SymBio Pharmaceuticals Limited stock price | 180 JPY |
Previous Close | 436 JPY |
Open | 437 JPY |
Bid | 439 JPY x 0 |
Ask | 442 JPY x 0 |
Day's Range | 437 - 453 JPY |
52 Week Range | 356 - 911 JPY |
Volume | 690.8K JPY |
Avg. Volume | 613.08K JPY |
Market Cap | 17.94B JPY |
Beta (5Y Monthly) | 0.709961 |
PE Ratio (TTM) | 17.06843 |
EPS (TTM) | -49.19 JPY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
4582.T Valuation Measures
Enterprise Value | 12.24B JPY |
Trailing P/E | 17.06843 |
Forward P/E | 11.227622 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.9416611 |
Price/Book (mrq) | 2.0377188 |
Enterprise Value/Revenue | 1.325 |
Enterprise Value/EBITDA | 7.621 |
Trading Information
SymBio Pharmaceuticals Limited Stock Price History
Beta (5Y Monthly) | 0.709961 |
52-Week Change | -34.63% |
S&P500 52-Week Change | 20.43% |
52 Week High | 911 JPY |
52 Week Low | 356 JPY |
50-Day Moving Average | 409.96 JPY |
200-Day Moving Average | 577.74 JPY |
4582.T Share Statistics
Avg. Volume (3 month) | 613.08K JPY |
Avg. Daily Volume (10-Days) | 566.75K JPY |
Shares Outstanding | 39.61M |
Float | 36.57M |
Short Ratio | N/A |
% Held by Insiders | 7.71% |
% Held by Institutions | 4.92% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 11.04% |
Operating Margin (ttm) | 16.30% |
Gross Margin | 75.19% |
EBITDA Margin | 17.38% |
Management Effectiveness
Return on Assets (ttm) | 10.68% |
Return on Equity (ttm) | 13.26% |
Income Statement
Revenue (ttm) | 9.24B JPY |
Revenue Per Share (ttm) | 234.85 JPY |
Quarterly Revenue Growth (yoy) | -33.30% |
Gross Profit (ttm) | 7.6B JPY |
EBITDA | 1.61B JPY |
Net Income Avi to Common (ttm) | 1.02B JPY |
Diluted EPS (ttm) | 25.72 |
Quarterly Earnings Growth (yoy) | -97.50% |
Balance Sheet
Total Cash (mrq) | 5.94B JPY |
Total Cash Per Share (mrq) | 149.95 JPY |
Total Debt (mrq) | 0 JPY |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 10.137 |
Book Value Per Share (mrq) | 215.437 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of SymBio Pharmaceuticals Limited
Country | Japan |
State | N/A |
City | Tokyo |
Address | Toranomon 30 Mori Building |
ZIP | 105-0001 |
Phone | 81 3 5472 1125 |
Website | https://www.symbiopharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 122 |
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs and other related activities in the areas of oncology and hematology in Japan and internationally. It offers SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, chronic lymphocytic leukemia, and relapsed/refractory diffuse large B-cell lymphoma; SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid administrator under the TREAKISYM name. The company also engages in the development of SyB L-1101, an intravenous formulation, which completed Phase III clinical trial for the treatment of higher-risk myelodysplastic syndromes (HR-MDS); and SyB C-1101, an oral formulation that is in Phase I/II clinical trial in combination with AZA to treat HR-MDS. In addition, it is involved in the development SyB V-1901, an antiviral drug. SymBio Pharmaceuticals Limited was incorporated in 2005 and is based in Tokyo, Japan.
Q&A For SymBio Pharmaceuticals Limited Stock
What is a current 4582.T stock price?
SymBio Pharmaceuticals Limited 4582.T stock price today per share is 180 JPY.
How to purchase SymBio Pharmaceuticals Limited stock?
You can buy 4582.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SymBio Pharmaceuticals Limited?
The stock symbol or ticker of SymBio Pharmaceuticals Limited is 4582.T.
Which industry does the SymBio Pharmaceuticals Limited company belong to?
The SymBio Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does SymBio Pharmaceuticals Limited have in circulation?
The max supply of SymBio Pharmaceuticals Limited shares is 44.75M.
What is SymBio Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
SymBio Pharmaceuticals Limited PE Ratio is now.
What was SymBio Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
SymBio Pharmaceuticals Limited EPS is -49.19 JPY over the trailing 12 months.
Which sector does the SymBio Pharmaceuticals Limited company belong to?
The SymBio Pharmaceuticals Limited sector is Healthcare.